Author Biography

Dr. Amit Pande, PhD: Introduction & Mission

I am Dr. Amit Pande, and my professional foundation is built on solid scientific principles. I hold a PhD in Biotechnology from Sri Venkateshwara University (SVU, India), where I specialized in molecular and clinical research.

I dedicate my scientific authority to medihealth PRO to ensure the information is precise and verifiable. I aim to address the critical gap where complex medical science is often too difficult to apply practically in daily life.

I use decades of my research experience to validate health information, clarify complex scientific concepts, and ensure all guidance is simple, clear, and strictly evidence based. In addition, I translate laboratory science into practical, real world guidance. As a result, readers can make confident, informed decisions about their health.

Academic Credentials, Professional Certifications & Core Expertise

My advanced specialization gives me the necessary authority to analyze health claims at the molecular and cellular level. Every article on medihealth PRO is built on this foundational science.

Primary Qualification

Professional Certifications & Technical Training

Core Expertise

  • Immunology & Transplantation: Advanced assessment of systemic immune responses and transplant rejection risks. I utilize Luminex xMAP and Thermo Fisher (One Lambda) technologies to analyze HLA antibodies and Donor-Specific Antibodies (DSA).
  • Hematology & Transfusion Medicine: Expertise in the clinical complexities of leucodepletion and transfusion-related alloimmunization. I evaluate how blood-based cellular changes impact systemic immunity and long-term health outcomes.
  • Genomics & Molecular Diagnostics: Mastery of high-complexity platforms, including Next-Generation Sequencing (NGS) and Real-Time PCR (qPCR) via Roche systems. I specialize in interpreting genomic blueprints to provide precise, personalized health insights.
  • Cell Signaling & Endocrinology: Decoding the biochemical pathways and hormonal signaling mechanisms that facilitate cellular communication. This expertise is critical for understanding metabolic balance, stress response, and endocrine health.
  • Microbiology & The Microbiome: Scientific analysis of microbial communities and their profound influence on gut health, chronic inflammation, and immune modulation.
  • Regenerative Medicine: Deep understanding of stem cell biology and translational applications. I specialize in the characterization of hematopoietic stem cells (CD34+) and the monitoring of immune reconstitution through T-cell subset analysis (CD3, CD4, and CD8).
  • Clinical Research & Data: Applying ISO 15189 standards to evidence-based research. I specialize in the rigorous interpretation of complex molecular data to filter medical facts from health myths.

The Scientific Lens: From Lab to Life

I translate the same rigorous scientific approach required for analyzing clinical data to explain everyday health concerns.

I focus on uncovering the biological “why” behind issues like hormonal shifts, sleep patterns (e.g., sleep regression), chronic inflammation, and immune challenges. My goal is to connect real-world health outcomes to their cellular and molecular roots in a simple, understandable way, ensuring every piece of information you receive is fully backed by science.

Peer-Reviewed Publications (The Authority Anchor)

Verifiable Authority: I have authored or co-authored over 50 peer-reviewed international research papers and case studies in specialized medical fields, including Renal Transplantation and Transfusion Medicine. This track record in publishing high-level clinical research establishes the integrity and rigor of my work.

Selected Publications & Research Portfolio:

  • A retrospective observational study to estimate the risk of HLA alloimmunization with blood transfusion: Can the risk be reduced by leucodepletion? Immunobiology. 2023. View on ScienceDirect ↗︎
  • Detection of donor-specific HLA antibodies: A retrospective observation in 350 renal transplant cases. Transpl Immunol, 2023. View on PubMed ↗︎
  • Effects of Different Sensitization Events on HLA Alloimmunization in Renal Transplant Cases; a Retrospective Observation in 1066 Cases. Transplant Immunology, 2022. View on PubMed ↗︎
  • Significance of Luminex-crossmatch assay and its mean fluorescence intensity-a retrospective observation in 380 renal transplant cases. Polish journal of surgery, 2022. View on Polish Journal of Surgery. View on Polish Journal of Surgery ↗︎
  • A Case of Successful Desensitization in High Risk HLA Incompatible Kidney Transplantation. Indian J Nephrol, 2021. View on Science Direct ↗︎
  • Clinical outcome of living donor kidney transplantation across simultaneous ABO and HLA incompatibility: Single center experience of first ten cases. Transfus Apher Sci, 2021. View on PubMed ↗︎
  • Desensitization Therapy in Kidney Transplantation Cases with Positive Baseline Complement-Dependent Cytotoxicity Crossmatch and High Donor-Specific Antibodies: A Retrospective Study. Indian Journal of Transplantation, 2021. Indian Journal of Transplantation ↗︎
  • Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants. J Clin Apher, 2021. Journal of Clinical Apheresis↗︎
  • Renal transplantation in HLA sensitized patients: Traversing the immunological barrier. Therapeutic Apheresis and Dialysis, 2020. View on PubMed ↗︎
  • Comparative Study for Measurement of Residual Leucocytes in Leuco-depleted Red Blood Cells by Two Different Methods. Indian journal of hematology and blood transfusion, 2020. View on PubMed ↗︎
  • Extraoral plasmablastic lymphoma detected using ascitic fluid cytology and flow cytometry: a case report with a review of the literature. Acta Cytol. 2014;58(3):309-17. View on PubMed ↗︎
  • Stability of eosin-5′-maleimide dye used in flow cytometric analysis for red cell membrane disorders. Blood Res. 2015 Jun;50(2):109-12. View on PubMed ↗︎
  • CD5 positive hairy cell leukemia: A rare case report with brief review of literature. Cytometry B Clin Cytom. 2016 Sep;90(5):467-72. View on PubMed ↗︎
  • Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia. Indian J Pathol Microbiol. 2016 Jul-Sep;59(3):310-3. View on PubMed ↗︎
  • Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases. J Immunoassay Immunochem. 2021 May 4;42(3):300-313. View on PubMed ↗︎
  • Hepatosplenic T Cell Lymphoma in an Immunocompetent Female Diagnosed using Flow Cytometry: A Rare Clinical Entity. J Clin Diagn Res. 2016 Aug;10(8):ED15-6. View on PubMed ↗︎
  • Aberrant NK cell associated marker (CD56 and CD57) expression in chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2015 Sep-Oct;88(5):348-51. View on PubMed ↗︎
  • Detection of T and B cells specific complement-fixing alloantibodies using flow cytometry: A diagnostic approach for a resource limited laboratory. Asian J Transfus Sci. 2017 Jul-Dec;11(2):171-179. View on PubMed ↗︎
  • Primary follicular lymphoma of the breast: a rare clinical entity diagnosed using tissue flow cytometry. Indian J Hematol Blood Transfus. 2015 Jun;31(2):300-1. View on PubMed ↗︎
  • Renal transplantation in HLA sensitized patients: Traversing the immunological barrier. Ther Apher Dial. 2020 Oct;24(5):578-590. View on PubMed ↗︎

Verifiable Research Profiles

To view my complete research history, please visit my official profiles: View My Research Profile on ORCID ↗︎

⚠️Medical Disclaimer: Dr. Amit Pande’s content on medihealth PRO is for informational and educational purposes only and is not a substitute for professional medical diagnosis, treatment, or advice. Always consult with a qualified healthcare provider.